Antimicrobial Symposium by Soper, David E.
Infectious Diseases in Obstetrics and Gynecology 3:175 (1995)
(C) 1996 Wiley-Liss, Inc.
Antimicrobial Symposium
The Journal recognizes the influx of new antimicrobials onto the clinical scene. Our
desire is to offer the reader an up-to-date, succinct, and practical appraisal of these
newer antimicrobials and the clinician a resource from which to make clinical decisions
as to their use in practice. The Journal welcomes suggestions from its audience
concerning other antimicrobials they would like to see reviewed.
This issue of Infectious Diseases in Obstetrics and Gynecology introduces a new section
which will become a standing feature, "Antimicrobial Symposium." Anti-infective
agents have been utilized for thousands of years. The discovery and clinical use of
the sulfonamides in 1936 ushered in the modern era of chemotherapy. With the
subsequent development of penicillin and streptomycin in the 1940s, the "golden
age" of antimicrobial chemotherapy had arrived. The continued development of
effective antimicrobial drugs has revolutionized the management of infectious diseases
over the past 50 years.
The pharmaceutical industry has long recognized the market for effective antimi-
crobials. With more than $2.4 billion being spent annually on oral antibiotics alone,
these agents are some of the most commonly prescribed drugs dispensed by pharmac-
ies in this country, The continued development of agents with preferred pharmacoki-
netic profiles, oral dosing, and selective anti-infective spectra has improved the clini-
cian’s ability to treat infections by decreasing side effects and improving patient
compliance. In addition, continued availability of anti-infectives in a timely manner
to address emerging problems in infectious diseases and to overcome the difficulties
posed by microbial resistance to older anti-infective drugs is ofparamount importance)
Infection remains the single most common clinical problem encountered by the
obstetrician-gynecologist. An up-to-date understanding of the large number of new
agents being introduced in the market is imperative. This section will focus on
newer anti-infective agents in an attempt to allow the clinician to review the clinical
applications of these agents with respect to their effectiveness, pharmacokinetics, side
effects, and cost. We hope that this section will help you make a rational decision as
to the utility of the reviewed agents in your practice. In addition, the compendium
of articles at the year’s end should serve as a valuable resource as you review your
prescribing habits.
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